Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penetration of Brimonidine in Human Vitreous Body after Aibeta Instillation
jRCTs051200008Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Aibeta in chorioretinal scar and Full Thickness Macular Hole (FTMH), sponsored by Senju Pharmaceutical Co., Ltd. Started Jun 2020; status: completed.
02
Drugs
Aibeta
03
Conditions
chorioretinal scarFull Thickness Macular Hole (FTMH)
Beyond the preview
Go deeper on jRCTs051200008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200008.